| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10909005 | Leukemia Research | 2013 | 6 Pages |
Abstract
In conclusion, administration of azacitidine is effective in AML patients with 20-30% and >30% BM blasts.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
L.H. van der Helm, N.J.G.M. Veeger, M. van Marwijk Kooy, A. Beeker, O. de Weerdt, M. de Groot, C. Alhan, M. Hoogendoorn, L. Laterveer, A.A. van de Loosdrecht, J. Koedam, E. Vellenga, G. Huls,